The firm is a U.S.-based life sciences venture development and investment organization focused on supporting early-stage biotechnology and medical technology companies. The firm invests from Pre-Seed through Series A and combines financial investment with laboratory infrastructure, specialized equipment, operational resources, and company-building support. The firm utilizes multiple investment structures, including direct early-stage equity investments and in-kind arrangements that provide access to laboratory facilities and other resources in exchange for equity. The firm primarily operates within major U.S. life sciences innovation ecosystems.
The firm invests exclusively in life sciences, including therapeutics, medical devices, diagnostics, biotechnology platforms, and enabling healthcare technologies. Areas of interest include drug discovery, precision medicine, oncology, cell and gene therapies, advanced diagnostics, medical technologies, and life science tools. The firm prioritizes differentiated scientific innovations with strong translational potential and meaningful clinical applications. The firm is particularly interested in very early-stage technologies emerging from academic institutions, research centers, and healthcare systems that can benefit from dedicated infrastructure and company development support.
From a company and management team perspective, the firm seeks founders and technical teams developing scientifically differentiated technologies with strong commercial potential. The firm places significant emphasis on scientific validation, technical expertise, and the ability to address substantial unmet medical needs. The firm provides hands-on support in company formation, fundraising, operational strategy, talent recruitment, and commercialization planning. The firm also facilitates access to scientific advisors, industry partners, institutional investors, and specialized research infrastructure to accelerate portfolio company development.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
